Cargando…
New Approaches in the Development of a Vaccine for Mucosal Candidiasis: Progress and Challenges
The commensal fungus Candida albicans causes mucosal candidiasis in the rapidly expanding number of immunocompromised patients. Mucosal candidiasis includes oropharyngeal, esophageal, gastrointestinal, and vaginal infections. Vulvovaginal candidiasis (VVC) and antimycotic-refractory recurrent VVC is...
Autores principales: | Vecchiarelli, Anna, Pericolini, Eva, Gabrielli, Elena, Pietrella, Donatella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417234/ https://www.ncbi.nlm.nih.gov/pubmed/22905033 http://dx.doi.org/10.3389/fmicb.2012.00294 |
Ejemplares similares
-
Chronic Vaginal Candidiasis Is Achievable in Outbred CD-1 Mice
por: Gabrielli, Elena, et al.
Publicado: (2017) -
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019) -
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration
por: Pericolini, Eva, et al.
Publicado: (2018) -
Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis
por: Pietrella, Donatella, et al.
Publicado: (2011) -
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis
por: Pericolini, Eva, et al.
Publicado: (2016)